Attending Physician, Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Member of the Integrative Oncology Committee of the China Anti-Cancer Association and the Youth Committee for Breast Cancer of the Shanghai Anti-Cancer Association.

Principal Investigator of two projects funded by the National Natural Science Foundation of China (NSFC), and has participated in multiple research projects supported by the NSFC and the Shanghai Municipal Science and Technology Commission.

Published 18 SCI papers in journals such as Research, Molecular Cancer, MedComm, and Oncogene over the past three years, with a total impact factor of 150. Contributor to two medical monographs. Research findings presented at the San Antonio Breast Cancer Symposium (SABCS) through poster sessions.

Dedicated to medical science education, with popular science works frequently ranking at the top of sales charts in the category.

Co-author of the “Chinese Expert Consensus on the Prevention, Diagnosis, and Management of Solid Tumor Patients During the COVID-19 Pandemic (2022 Edition)” and the “Expert Consensus on the Management of Skin Adverse Reactions Related to Anti-Tumor Drugs.”